Out of four T-ALL patients in the diagnostic and extension cohorts who relapsed, two harbored mutations in ARID1A. The mutations included a nonsense SNV and a nsSNV that introduced a proline at a position where it is likely to disrupt DNA binding (Table 3, Supplementary Table S5). Here, ARID1A is linked to acute lymphoblastic leukemia.